Men's and Women's
Specialty Health Centers
866-322-2263
Hormone and Infertility Clinic in Noblesville, Indiana

Ovarian Cancer

Ovarian Cancer
“Armed with the results of genetic testing, you can take steps to potentially prevent the disease, delay its onset, or catch it at an earlier stage when outcomes are likely to be better. ”
-- Kristi Marsella, N.P.
 
Ovarian cancer screenings are used to detect ovarian cancer. If ovarian irregularities are suspected to be present (following an abnormal pelvic exam), doctors may use ultrasonography and check for higher CA 125 levels. Ultrasonography is used to detect irregularities in ovary shape and any masses present.
 
Recognize the signs and beat ovarian cancer

B loating that is persistent
E ating less and feeling fuller
A bdominal pain
T rouble with your bladder
 
Ovarian Cancer Links:

BRACAnalysis

BRACAnalysis, a simple blood test by Myriad Genetics, assesses a woman’s risk of developing ovarian cancer based on detection of mutations in the BRCA 1 and BRCA 2 genes.
 
Recently this test has become the standard of care in identification of individuals with a family history of ovarian cancer and is currently being offered at Women’s Specialty Health Centers.
 
Both Dr. McLaughlin and Nurse Practitioner, Kristi Marsella are educators and guest speakers for Myriad Genetics where they are actively involved in counseling women, as well as other physicians about the hereditary risk factors and testing for ovarian cancer.
 
If you have a strong family history or specific questions please contact our office today @ 317-774-1200.
More information can be found by clicking on the “BRACAnalysis_Myriad Genetics” link below:
 
BRACAnalysis Myriad Genetics

Ca 125

Ca 125 is an antigen (part of the immune system’s cellular makeup) that is present in higher amounts when cancers may be present. However, elevated levels of Ca 125 do not indicate conclusively the presence of cancer. Higher levels are also found in patients with a history of diverticulitis, patients who are pregnant, and patients with uterine fibroids.